Latuda and Azithromycin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Latuda (lurasidone hydrochloride) and Azithromycin (azithromycin). Common drug interactions include chronic kidney disease among females and atypical mycobacterial pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Latuda and Azithromycin. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Latuda?

Latuda has active ingredients of lurasidone hydrochloride. It is often used in bipolar disorder. eHealthMe is studying from 21,543 Latuda users. Check the latest studies of Latuda.

What is Azithromycin?

Azithromycin has active ingredients of azithromycin. It is often used in sinusitis. eHealthMe is studying from 40,716 Azithromycin users. Check the latest studies of Azithromycin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 30, 2026

30 people who take Latuda and Azithromycin together, and have interactions are studied.

Latuda and Azithromycin drug interactions.

What are the common drug interactions of Latuda and Azithromycin, by gender? *:

female:

  1. Chronic kidney disease
  2. Renal failure (kidney dysfunction)
  3. Anxiety
  4. Asthma
  5. Kidney infection
  6. Premature separation of placenta
  7. Stillbirth (a birth of dead foetus)
  8. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  9. Urinary tract infection
  10. Vaginal haemorrhage (vaginal bleeding)

male:

  1. Atypical mycobacterial pneumonia (infections caused by several types of mycobacterium similar to the germ that causes tuberculosis)
  2. Back pain
  3. Diarrhoea
  4. Fungal infection
  5. Gastric bypass
  6. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  7. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  8. Pain
  9. Renal failure (kidney dysfunction)
  10. Respiratory tract congestion (blockage on respiratory system)

What are the common drug interactions of Latuda and Azithromycin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  2. Morning sickness (sickness in morning during pregnancy)
  3. Asthma
  4. Cystic fibrosis (disease of the secretary glands)
  5. Pneumonia
  6. Renal failure (kidney dysfunction)

30-39:

  1. Anxiety
  2. Chronic kidney disease
  3. Renal failure (kidney dysfunction)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Emotional distress
  6. Kidney infection
  7. Nephrogenic anaemia (anaemia due to kidney disease)
  8. Nephrolithiasis (calculi in the kidneys)
  9. Osteoarthritis (a joint disease caused by cartilage loss in a joint)
  10. Pain

40-49:

  1. Chronic kidney disease

50-59:

  1. Kidney infection
  2. Memory impairment
  3. Oxygen saturation decreased
  4. Pneumonia
  5. Sleep disorder
  6. Upper respiratory tract infection
  7. Urinary tract infection
  8. Viral infection
  9. Rash
  10. Abdominal pain upper

60+:

  1. Chronic kidney disease
  2. Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
  3. Pneumonia
  4. Renal failure (kidney dysfunction)

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 9 people, 30.00%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 26.67%
  3. Pain: 5 people, 16.67%
  4. Immunodeficiency Common Variable: 5 people, 16.67%
  5. Infection: 4 people, 13.33%
  6. Depression: 4 people, 13.33%
  7. High Blood Cholesterol: 4 people, 13.33%
  8. Hypersensitivity: 3 people, 10.00%
  9. High Blood Pressure: 3 people, 10.00%
  10. Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Latuda and Azithromycin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Latuda and Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Latuda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Azithromycin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Latuda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Azithromycin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lurasidone hydrochloride and azithromycin (the active ingredients of Latuda and Azithromycin, respectively), and Latuda and Azithromycin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: